Real-time enrollment status for this solid tumors clinical trial
Current Status
Recruiting
Checked: September 13, 2026 at 5:41 PM UTC
| NCT Number | NCT04198766 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 340 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Inhibrx Biosciences, Inc |
| Last Updated on CT.gov | July 29, 2026 (Jul 29, 2026) |
As of September 13, 2026: Clinical trial NCT04198766 is currently recruiting participants. This phase1 study for solid tumors is actively seeking new participants at 30 locations across the United States. The study is sponsored by Inhibrx Biosciences, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04198766 is actively recruiting participants as of September 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04198766 was last updated Jul 29, 2026 (July 29, 2026). HelloStudys verifies this status automatically.